alk

ALK receives positive recommendation for EURneffy 1 mg: A needle-free anaphylaxis treatment for children

Inside Information ALK (ALKB:DC / OMX: ALK B) today announced that the Committee for Medicinal Products for Human Use (‘CHMP’)…

1 week ago

ALK and GenSci partner to expand the AIT market in China

Inside Information GenSci is granted exclusive rights to ALK’s house dust mite AIT products in China. ALK will be eligible…

5 months ago